Stefanie N Rezansoff1, A Moniruzzaman2, S Fazel3, R Procyshyn4, J M Somers2. 1. Faculty of Health Sciences, Simon Fraser University, 8888 University Drive, Burnaby, BC, V5A 1S6, Canada. sra20@sfu.ca. 2. Faculty of Health Sciences, Simon Fraser University, 8888 University Drive, Burnaby, BC, V5A 1S6, Canada. 3. Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, 0X3 7JX, UK. 4. Department of Psychiatry, Faculty of Medicine, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, V6T 2A1, Canada.
Abstract
PURPOSE: The purpose of this study was to investigate the level of adherence to antipsychotic prescription medication in a well-defined homeless cohort over a 15-year period. We hypothesized that adherence would be well below the recommended threshold for clinical effectiveness (80 %), and that it would be strongly associated with modifiable risk factors in the social environment in which homeless people live. METHOD: Linked baseline data (including comprehensive population-level administrative prescription records) were examined in a subpopulation of participants from two pragmatic-randomized trials that investigated Housing First for homeless and mentally ill adults. Adherence to antipsychotic medication was operationalized using the medication possession ratio. Multivariable logistic regression was used to estimate effect sizes between socio-demographic, homelessness-related and illness factors, and medication possession ratio. RESULTS: Among the 290 participants who met inclusion criteria for the current analysis, adherence to antipsychotic prescription was significantly associated with: history of psychiatric hospitalization; receipt of primary medical services; long-acting injectable antipsychotic formulations; and duration of homelessness. Mean medication possession ratio in the pre-randomization period was 0.41. Socio-demographic characteristics previously correlated with antipsychotic non-adherence were not significantly related to medication possession ratio. CONCLUSIONS: This is the first study to quantify the very low level of adherence to antipsychotic medication among homeless people over an extended observation period of 15 years. Each of the four factors found to be significantly associated with adherence presents opportunities for intervention. Strategies to end homelessness for this population may represent the greatest opportunity to improve adherence to antipsychotic medication.
PURPOSE: The purpose of this study was to investigate the level of adherence to antipsychotic prescription medication in a well-defined homeless cohort over a 15-year period. We hypothesized that adherence would be well below the recommended threshold for clinical effectiveness (80 %), and that it would be strongly associated with modifiable risk factors in the social environment in which homeless people live. METHOD: Linked baseline data (including comprehensive population-level administrative prescription records) were examined in a subpopulation of participants from two pragmatic-randomized trials that investigated Housing First for homeless and mentally ill adults. Adherence to antipsychotic medication was operationalized using the medication possession ratio. Multivariable logistic regression was used to estimate effect sizes between socio-demographic, homelessness-related and illness factors, and medication possession ratio. RESULTS: Among the 290 participants who met inclusion criteria for the current analysis, adherence to antipsychotic prescription was significantly associated with: history of psychiatric hospitalization; receipt of primary medical services; long-acting injectable antipsychotic formulations; and duration of homelessness. Mean medication possession ratio in the pre-randomization period was 0.41. Socio-demographic characteristics previously correlated with antipsychotic non-adherence were not significantly related to medication possession ratio. CONCLUSIONS: This is the first study to quantify the very low level of adherence to antipsychotic medication among homeless people over an extended observation period of 15 years. Each of the four factors found to be significantly associated with adherence presents opportunities for intervention. Strategies to end homelessness for this population may represent the greatest opportunity to improve adherence to antipsychotic medication.
Authors: Claudia Leucht; Stephan Heres; John M Kane; Werner Kissling; John M Davis; Stefan Leucht Journal: Schizophr Res Date: 2011-01-22 Impact factor: 4.939
Authors: Daniel Dassa; Laurent Boyer; Michel Benoit; Stéphane Bourcet; Philippe Raymondet; Thierry Bottai Journal: Aust N Z J Psychiatry Date: 2010-10 Impact factor: 5.744
Authors: Karen Dahri; Stephen J Shalansky; Linda Jang; Leon Jung; Andrew P Ignaszewski; Catherine Clark Journal: Ann Pharmacother Date: 2008-02-26 Impact factor: 3.154
Authors: Marcia Valenstein; Janet Kavanagh; Todd Lee; Peter Reilly; Gregory W Dalack; John Grabowski; David Smelson; David L Ronis; Dara Ganoczy; Emily Woltmann; Tabitha Metreger; Patricia Wolschon; Agnes Jensen; Barbara Poddig; Frederic C Blow Journal: Schizophr Bull Date: 2009-11-21 Impact factor: 9.306
Authors: Kei Yoshimatsu; Andrea Elser; Melanie Thomas; James Dilley; Deborah Barnes; Alexandra Ballinger; Steven Wozniak; Christina Mangurian Journal: Community Ment Health J Date: 2019-05-17
Authors: A Tinland; K Zemmour; P Auquier; M Boucekine; V Girard; S Loubière; G Fond; Laurent Boyer Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2017-06-27 Impact factor: 4.328
Authors: James Lachaud; Cilia Mejia-Lancheros; Michael Liu; Ri Wang; Rosane Nisenbaum; Vicky Stergiopoulos; Stephen W Hwang; Patricia O'Campo Journal: Front Nutr Date: 2021-05-12
Authors: Sahar S Eshtehardi; Ashley A Taylor; Tzuan A Chen; Marcel A de Dios; Virmarie Correa-Fernández; Darla E Kendzor; Michael S Businelle; Lorraine R Reitzel Journal: Int J Environ Res Public Health Date: 2021-07-28 Impact factor: 4.614